Prognostic implication of macrocytosis on adverse outcomes after coronary intervention.

[1]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[2]  M. Sangoi,et al.  Relation between red blood cell distribution width and mortality after acute myocardial infarction. , 2011, International journal of cardiology.

[3]  I. Rosenberg,et al.  Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. , 2010, The American journal of clinical nutrition.

[4]  Robert Dufour,et al.  Canadian Cardiovascular Society / Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations , 2009 .

[5]  Torben Hansen,et al.  Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort , 2009, Diabetes Care.

[6]  Deepak L. Bhatt,et al.  Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia. , 2009, JACC. Cardiovascular interventions.

[7]  Y. Shinohara,et al.  Outline of the Japanese Guidelines for the Management of Stroke 2004 and Subsequent Revision , 2008, International journal of stroke : official journal of the International Stroke Society.

[8]  Renata Cifkova,et al.  Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) , 2007 .

[9]  C. Spadaccio,et al.  The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study. , 2007, Clinical therapeutics.

[10]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[11]  S. Yale,et al.  Megaloblastic anemia and other causes of macrocytosis. , 2006, Clinical medicine & research.

[12]  P. Matarrese,et al.  The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: an ex vivo and in vitro study. , 2006, Antioxidants & redox signaling.

[13]  S. Bonovas,et al.  Redox imbalance, macrocytosis, and RBC homeostasis. , 2006, Antioxidants & redox signaling.

[14]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  G. FitzGerald,et al.  Oxidative stress and cardiovascular injury: Part II: animal and human studies. , 2003, Circulation.

[16]  G. FitzGerald,et al.  Oxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS , 2003, Circulation.

[17]  Eric J Topol,et al.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[18]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[19]  A. Ogundipe,et al.  Etiology and diagnostic evaluation of macrocytosis. , 2000, The American journal of the medical sciences.

[20]  R. Yip,et al.  World Health Organization hemoglobin cut-off points for the detection of anemia are valid for an Indonesian population. , 1999, The Journal of nutrition.

[21]  C. Hook,et al.  A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia. , 1992, The Medical clinics of North America.

[22]  F. Breedveld,et al.  The clinical significance of macrocytosis. , 2009, Acta medica Scandinavica.

[23]  P. Hamilton,et al.  High mean red cell volume: its incidence and significance in routine haematology. , 1978, Journal of clinical pathology.